Prevention of Events With Angiotensin-Converting Enzyme Inhibitor Therapy (PEACE)
Status:
Completed
Trial end date:
2005-06-01
Target enrollment:
Participant gender:
Summary
To determine whether the addition of angiotensin converting enzyme (ACE) inhibitor to
standard therapy in patients with known coronary artery disease and preserved left
ventricular function will prevent cardiovascular mortality and reduce the risk of myocardial
infarction.